EpimAb Biotherapeutics, a clinical stage biotechnology company specializing in the development of bispecific antibodies and T ...

Mestag Therapeutics has entered into a license and collaboration agreement with MSD (tradename of Merck & Co Inc) worth a ...

The first patient with advanced gastric and gastroesophageal cancer has been dosed in a trial combining PT886 with ...

Leads Biolabs’ LBL-024 receives Breakthrough Therapy Designation from China NMPA to treat extrapulmonary neuroendocrine carcinoma: Nanjing, China Thursday, October 10, 2024, 10: ...